Why is Trident Texofab falling/rising?

As of 26-Aug, Trident Texofab Ltd's stock is currently priced at Rs 237.45, reflecting a decrease of Rs 2.45, or 1.02%. The stock has recently experienced a trend reversal, falling after seven consecutive days of gains. Despite this decline, it remains close to its 52-week high, just 1.03% away from Rs 239.9. Over the past week, the stock has outperformed the sector by 0.95%, and its performance over the last year shows an impressive return of 444.61%. The company has reported positive results for the last three consecutive quarters, with net sales growing at 24.20%, which has contributed to its strong long-term performance.
In the broader market context, Trident Texofab's short-term return of +8.45% over the past week stands in stark contrast to the Sensex, which has declined by 1.05% during the same period. This indicates that the stock is performing well relative to the market. However, the recent drop in price may be attributed to profit-taking after a significant rally, as indicated by the stock's intraday low of Rs 225.4, which represents a 6.04% decline. Additionally, while trading in the sector has fallen by 2.1%, rising investor participation, as evidenced by a 22% increase in delivery volume, suggests ongoing interest in the stock despite the recent price drop.